Biomarkers for Alzheimer's disease: a controversial topic

Lancet Neurol. 2015 Aug;14(8):781-783. doi: 10.1016/S1474-4422(15)00150-7. Epub 2015 Jun 29.

Authors

Giovanni B Frisoni¹, Pieter Jelle Visser²

Affiliations

¹ University Hospitals and University of Geneva, Geneva, Switzerland; IRCCS Fatebenefratelli, Brescia, Italy. Electronic address: giovanni.frisoni@hcuge.ch.
² VU University Medical Centre, Amsterdam and Maastricht University, Maastricht, Netherlands.

PMID: 26139024
DOI: 10.1016/S1474-4422(15)00150-7

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease*
Amyloid beta-Peptides / metabolism*
Amyloidosis / metabolism*
Biomarkers*
Cerebral Cortex*
Disease Progression*
Female
Humans
Male

Substances

Amyloid beta-Peptides
Biomarkers